Beijing Biostar Pharmaceuticals Co., Ltd. announced that its auditors may issue a qualified opinion on the forthcoming annual results because of uncertainties surrounding the recoverability of an investment fund.

The company is currently engaging with the auditors to resolve the matter and stated that additional information will be provided in the full-year results announcement.

The board advised shareholders and potential investors to exercise caution when dealing in the company’s shares.